Active Ingredient(s): Vinorelbine
FDA Approved: * December 23, 1994
Pharm Company: * PIERRE FABRE
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Navelbine Overview

Vinorelbine (NVB), sold under the brand name Navelbine among others, is a chemotherapy medication used to treat a number of types of cancer.[3] This includes breast cancer and non-small cell lung cancer.[3] It is given by injection into a vein or by mouth.[3][1] Common side effects include bone marrow suppression, pain at the site of injection, vomiting, feeling tired, numbness, and diarrhea.[3] Other serious side...

Read more Navelbine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Navelbine Forums: RSS Feed


I had breast cancer in 1988 and 1994-lumpectomies, radiation, and in 1994, 5 years of Tamoxifen. Diagnosis 4-2010 of mets to right tibia,and T6 with other spots showing up on spine. Radiation to leg and T6. Started on Zometa and Faslodex monthly. Diagnosis 4-2011 with increased mets to spine, especially L1 and S1 Will be finishing radiation next week and starting Navelbine, Herceptin, ad continuing with Zometa. Anyone with similar concerns? Wondering what to expect with the new chemos.


Possible Dosages for this and Related Drugs:

  • Injection: 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Navelbine: (1 result)

Sorted by National Drug Code
  • 64370-532 Navelbine 10 mg/ml Intravenous Injection by Pierre Fabre Medicament

Other drugs which contain Vinorelbine or a similar ingredient: (1 result)

Related Navelbine Topics:

I had breast cancer in 1988 and 1994-lumpectomies, radiation, and in 1994, 5 years of Tamoxifen. Diagnosis 4-2010 of met...

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 June 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA